For example, although the numbers vary somewhat, in lung cancer, it has been reported that between 30%–60% of CD8 TILs and 5%–40% of CD4 TILs express CD69 and/or CD103 and were categorized as TRM.14 This evidence concerns the gene CD69 and lung carcinoma.